Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by IainCaimbeulon Apr 03, 2023 4:56pm
144 Views
Post# 35377182

RE:Ouch, down 17% today, looks like 0.055 imminent again

RE:Ouch, down 17% today, looks like 0.055 imminent againQues: "Why down almost 20% today?" 

Answer: James R Howard-Tripp. He is incapable of EXECUTING, I mentioned lack of execution about two years ago and was slagged for saying so. Expect it to go even lower than $0.075.

That so called presentation was a disgrace . Just a re-shuffle of slides and more blah blah blah. No mention of companies actually signed up. Following on the heels of a abysmal year end and Q4 report.

Tripp is NOT a public speaker, thick tongue, has the Brit word mumble down to a science, coughed throughout the presentation (could they not have edited that out or did a retake as it wasn't live anyway). Not even the pretense of having questions.

I feel embarassed to own this stock and be part of this debacle, kind of like having a close relative working in a house of ill repute. Then you have the likes of gojotv trying to milk some good news out of the Grail post (by nailbiter2 - no actual mention of Stagezero but hey it may help to deflect from reality); oh and don't forget the "game changing" recent nurse hire - yup gojotv again. Is there no end to the sheer lunancy?

's mise gu dleas - (yours faithfully)  Iain 
James R Howard-Tripp Chairman and CEOJames R Howard-Tripp Chairman and CEO James R Howard-Tripp Chairman and CEO James R Howard-Tripp Chairman and CEO 
<< Previous
Bullboard Posts
Next >>